Actively Recruiting
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-06
250
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is a retrospective-prospective, single-centre, non-pharmacological, retrospective tissue study carried out for scientific and health protection purposes. It involves the systematic collection of clinical information from patients diagnosed with PT-TMA
CONDITIONS
Official Title
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Recipient of living kidney transplant, brain death cadaver donor, cardiac death cadaver donor, single kidney transplant, double kidney transplant, or combined kidney transplant
- Provided informed consent to participate and to allow processing of personal, special, and genetic data
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Sant'Orsola University Hospital - Nephrology, Dialysis and Transplant Unit
Bologna, BO, Italy, 40138
Actively Recruiting
Research Team
M
MARCELLO DEMETRI, BIOLOGY
CONTACT
G
Giorgia Comai, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here